Comments

CervoMed Stock Price, Quotes and Forecasts

Q: What sector and industry does CervoMed (CRVO) operate in?

CervoMed is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

CRVONASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$6.05

-1.06-14.85%

At close: -

$6.10

0.050.85%

After Hours: Jun 27, 6:25 PM EDT

CervoMed (CRVO) Forecast

News Earnings CervoMed (CRVO) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

CervoMed Stock Price, Quotes and Forecasts | NASDAQ:CRVO | Benzinga

Explore CervoMed stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CRVO.

Open	$7.09
Close	$6.05
Volume / Avg.	739.70K / 452.92K
Day Range	$6.05 - $7.10
52 Wk Range	1.80 - 20.63
Market Cap	$53.10M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	33
Short Interest	4.69%
Days to Cover	2.14

Recent News

EXCLUSIVE: March's 20 Most-Searched Tickers On Benzinga Pro — Where Do Tesla, Nvidia, Apple, Applovin Stock Rank?

A look at the top 20 most-searched stocks on Benzinga Pro in March. While many had news in the month that could affect rankings, the trends could be a sign of what's to come.

Chris Katje

CervoMed's Dementia Study's 16-Week Data 'Compelling Enough To Move From Sidelines' Analyst Says

CervoMed's Phase 2b study extension shows improved cognitive outcomes with neflamapimod, leading to an analyst upgrade and increased confidence in the drug.

Vandana Singh

This Wells Fargo Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Mar

May

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$7.09
Close	$6.05
Volume / Avg.	739.70K / 452.92K
Day Range	$6.05 - $7.10
52 Wk Range	1.80 - 20.63
Market Cap	$53.10M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	33
Short Interest	4.69%
Days to Cover	2.14

About CervoMed Inc

Sector

Health Care

Industry

Biotechnology

CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for a...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy CervoMed (CRVO) stock?

You can purchase shares of CervoMed (NASDAQ:CRVO) through any online brokerage.

View our list of the best stock brokerages

Who are CervoMed (CRVO) competitors?

Other companies in CervoMed’s space includes: Zura Bio (NASDAQ:ZURA), Serina Therapeutics (AMEX:SER), Renovaro (NASDAQ:RENB), Gain Therapeutics (NASDAQ:GANX) and Armata Pharmaceuticals (AMEX:ARMP).

What is the forecast, or price target, for CervoMed (CRVO) stock?

CervoMed has a consensus price target of $25.57.

What is the current price for CervoMed (CRVO)?

The stock price for CervoMed (NASDAQ: CRVO) is $6.1012 last updated June 27, 2025 at 6:25 PM EDT.

Does CervoMed (CRVO) pay a dividend?

There are no upcoming dividends for CervoMed.

When is CervoMed (NASDAQ:CRVO) reporting earnings?

CervoMed’s Q2 earnings are confirmed for Friday, August 8, 2025.

Is CervoMed (CRVO) going to split?

There is no upcoming split for CervoMed.

What sector and industry does CervoMed (CRVO) operate in?

CervoMed is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.